Background {#Sec1}
==========

Among mammals, lifespan generally correlates with other life-history parameters such as gestation period and body mass \[[@CR1]\]. In this perspective, a subterranean rodent, the naked mole-rat (*Heterocephalus glaber*, NMR), and humans represent two species outliers by having an exceptionally long lifespan relative to their body mass. NMRs are eusocial animals that live in colonies where only a subgroup of animals is devoted to reproduction (usually a queen and one male called pasha) \[[@CR2]\]. NMRs exhibit other exceptional traits including lifelong fertility, resistance to infection, high regenerative capacity, and resistance to cancer and diabetes, reviewed in \[[@CR3], [@CR4]\]. For these reasons, NMRs have drawn attention of multiple studies aimed at identifying the molecular mechanisms behind their extreme longevity and resistance to age-related diseases. Comparative genome analysis has revealed positively selected genes in NMR (including genes involved in cellular respiration, translation, and regulation of oxidative stress) \[[@CR2], [@CR5]--[@CR7]\], and RNA-seq analysis suggested fewer changes in gene expression during aging as compared to other mammals \[[@CR6], [@CR8]\], supporting the view of enhanced maintenance of homeostasis in NMRs at the molecular level. NMRs possess enhanced protein stability and increased proteasomal activity in the liver \[[@CR9], [@CR10]\], negligible levels of cellular senescence \[[@CR11]\], increased resistance to irradiation-induced senescence and apoptosis \[[@CR12]\], over-activation of pathways that contribute to stress resistance (e.g., the nuclear factor erythroid2-related factor 2 (NFE2L2, previously NRF2/Nrf2) in the liver and fibroblasts and p53 in fibroblasts) \[[@CR3], [@CR13]\], atypical expression of extracellular matrix components by fibroblasts, such as high molecular mass hyaluronan, that confer resistance against cancer development \[[@CR14]\]. Intriguingly, NMRs have higher steady-state levels of oxidative damage compared to, e.g., mouse \[[@CR9], [@CR15]\], and possess mitochondria with unusual morphology in the heart and skeletal muscle \[[@CR16]\]. However, NMRs appear to be protected from the age-dependent increase in oxidative damage that manifest in other species \[[@CR9]\], presumably due to enhanced detoxifying systems \[[@CR17]\].

There is a wealth of evidence linking energy metabolism to the aging process and organism lifespan. Dietary interventions and nutrient sensing pathways have been shown to play a central role in modulating aging in different organisms \[[@CR18]--[@CR20]\]. Studies of genes under positive selection pressure across related species that show different lifespan have highlighted genes involved in mitochondrial homeostasis balance \[[@CR21]\], likely influencing both energy metabolism and hormetic responses affecting lifespan \[[@CR22]\]. Age-dependent changes of mitochondrial ultrastructure and activity have been described both in flies and mice \[[@CR23]\].

There is emerging evidence that metabolic changes in the NMR contribute to adaptation to its ecosystem \[[@CR24]\], allow to act as a "superorganism" with its eusocial life style \[[@CR4]\], and might be related to its extreme longevity. Given its central role in organism metabolism, we set out to investigate the liver of NMRs in order to identify novel molecular signatures of longevity. Since ecological adaptations are more likely to affect gene expression \[[@CR25]\], and mechanisms of aging act both at the transcript and protein level \[[@CR26]\], we performed a cross-species comparison between NMR and the shorter-lived guinea pig (*Cavia porcellus*, GP) using an integrated proteomic and transcriptomic approach. In order to investigate cross-species differences in the context of aging, we additionally analyzed the livers from young and old NMRs and related the identified changes to human aging by studying the liver proteome of 12 individuals aged between 31 and 88 years. Finally, we validated one of the newly identified longevity pathways to be a mediator of lifespan in the nematode *Caenorhabditis elegans.*

Results {#Sec2}
=======

Cross-species comparison of liver proteomes reveals elevated expression of detoxifying enzymes in naked mole-rats {#Sec3}
-----------------------------------------------------------------------------------------------------------------

We first compared the liver proteomes of young adult, non-breeder, male NMRs (2.7--3.8 years old (yo), *n* = 4) and GPs (0.7--1 years old, *n* = 4) using mass spectrometry (Additional file [1](#MOESM1){ref-type="media"}: Table S1). We chose GP as the most closely related rodent (\~ 41 mya divergence time \[[@CR7]\]) that displays a shorter lifespan as compared to NMR (maximum lifespan 12 years for GP vs. 31 years for NMR \[[@CR27]\]) and has a genome sequence available. For each animal, we obtained a quantitative proteome profile by liquid chromatography tandem mass spectrometry and estimated absolute protein abundances using the iBAQ method \[[@CR28]\]. In order to directly compare the two species, we mapped both NMR and GP proteins to the respective human orthologs and used these as the reference for comparison (see "[Methods](#Sec9){ref-type="sec"}" section). This allowed us to perform a quantitative comparison of the two species using estimated absolute abundances for 3248 protein groups quantified by at least two unique proteotypic peptides in both species (Fig. [1a](#Fig1){ref-type="fig"} and Additional file [2](#MOESM2){ref-type="media"}: Table S2). In order to validate our approach, we obtained RNA-seq data from the same samples and determined transcript-level fold changes between the two species. For this, only those reads that exclusively mapped to conserved regions were used, a method used for transcriptomic cross-species comparisons \[[@CR8]\] (Additional file [2](#MOESM2){ref-type="media"}: Table S2). Protein and transcript fold changes displayed a significant positive correlation (Pearson *R* = 0.52, *p* \< 2.2e−16, considering all the cross-quantified cases; Pearson *R* = 0.78, *p* \< 2.2e−16, considering all the cases significant in both dataset (*q* \< 0.1); Fig. [1b](#Fig1){ref-type="fig"}), which is in line with comparisons performed within the same species \[[@CR29]\]. Despite the general of trend of consistency, we also found a minority of genes that showed discordant fold changes at the transcript and protein level (Additional file [3](#MOESM3){ref-type="media"}: Figure S1A). Taken together, these data indicate that our strategy can reveal meaningful differences in protein abundance between species and that many of these changes are driven by changes in transcript levels.Fig. 1Cross-species comparison of the liver proteome integrated with RNA-seq from the same animals. **a** Liver proteomes from four adult naked mole-rats (NMRs) and four guinea pigs (GPs) were compared using quantitative mass spectrometry. Hierarchical clustering based on the correlation between proteome profiles based on 3248 protein groups quantified across the two species. **b** Comparison of NMR/GP fold changes estimated at the protein level by quantitative mass spectrometry and at the transcript level by RNA-seq. Colored dots indicate genes significant (*q* \< 0.1) in both comparisons. The names of selected genes that show consistent fold changes in the two comparisons are indicated. For RNA-seq analysis, only reads mapping to conserved regions between the two species were considered. **c** Heatmap showing NFE2L2 target genes significantly affected in NMR vs. GP. List of NFE2L2 basal target genes was obtained from \[[@CR30]\]. Only genes significant at both the transcript and protein level (*q* \< 0.1, corresponding to a combined *q* \< 0.05) are shown. Related to Additional file [1](#MOESM1){ref-type="media"}: Table S1, Additional file [2](#MOESM2){ref-type="media"}: Table S2, and Additional file [6](#MOESM6){ref-type="media"}: Figure S2

We next asked whether our comparison would reveal differential abundance of proteins that have been shown to influence lifespan in other organisms. We found strikingly higher levels of peroxiredoxin 1 (PRDX1) and thioredoxin reductase 1 (TXNRD1) in NMRs as compared to GPs (Fig. [1b](#Fig1){ref-type="fig"}). *PRDX1* and *TXNRD1* are both known targets of the transcription factor NFE2L2 \[[@CR30]\]. They display the strongest increase in NMR vs. GP among the 28 NFE2L2 target genes significantly affected at both the transcript and protein level (*q* \< 0.1, corresponding to a combined *q* \< 0.05, Fig. [1](#Fig1){ref-type="fig"}c and Additional file [2](#MOESM2){ref-type="media"}: Table S2). *PRDX1* and *TXNRD1* play a crucial role in maintaining cell redox homeostasis, and both of them have been shown to influence lifespan in multiple species by buffering ROS and promoting proteostasis \[[@CR31]--[@CR33]\]. Interestingly, PRDX1 and TXNRD1 are cytosolic enzymes, and their mitochondrial counterparts (PRDX5, TXNRD2) are instead expressed at similar levels in both species (Additional file [2](#MOESM2){ref-type="media"}: Table S2).

We next wondered whether we could identify similar differences in other organs. For this purpose, we compared RNA-seq data from the heart, skin, kidney, and cerebellum across the two species \[[@CR34]\] and found that increased transcript levels of *PRDX1* occur exclusively in the liver (Additional file [3](#MOESM3){ref-type="media"}: Figure S1B and S1C). This suggests that increased level PRDX1 and TXNRD1 might be linked to a specific metabolic activity of the NMR liver.

The liver of naked mole-rats has a unique metabolism characterized by reduced mitochondrial respiration and enhanced lipid metabolism {#Sec4}
-------------------------------------------------------------------------------------------------------------------------------------

Intrigued by this finding, we used gene set enrichment analysis to investigate differences in pathways and molecular networks between the long-lived and shorter-lived species. Our analysis returned pathways linked to energy metabolism (Fig. [2a](#Fig2){ref-type="fig"} and Additional file [4](#MOESM4){ref-type="media"}: Table S3). In particular, we found pathways related to lipid metabolism to be upregulated, and gene sets related to oxidative phosphorylation to be downregulated in NMR (*q* \< 0.05). Among upregulated proteins involved in lipid metabolism, we found enzymes responsible for fatty acid beta-oxidation (e.g., ACOX2 and ACOX3), and lipid (e.g., ACACA and ACSL5), cholesterol (e.g., MVD and DHCR24) and bile acids biosynthesis (e.g., AMACR) compared to GP (Fig. [2a](#Fig2){ref-type="fig"}, [b](#Fig2){ref-type="fig"} and Additional file [2](#MOESM2){ref-type="media"}: Table S2). Many of these are direct target of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARα), a master regulator of energy metabolism linked to aging \[[@CR35]\] (Fig. [2b](#Fig2){ref-type="fig"}). The majority of these enzymes showed higher abundance in the liver of NMRs both at transcript and protein level, irrespectively of their sub-cellular localization (Fig. [2b](#Fig2){ref-type="fig"}).Fig. 2Distinctive features of NMR liver metabolism. **a** Gene set enrichment analysis was performed on proteomic data. Gene sets are plotted according to the log~10~ value of the calculated enrichment score. Positive and negative values are used for gene sets showing higher and lower abundance in NMR, respectively. Because of the redundancy among the significantly affected gene sets (*q* \< 0.05), we highlighted representative categories of gene sets. The complete list of enriched gene sets is available in Additional file [4](#MOESM4){ref-type="media"}: Table S3. **b** Protein (Prot.) and transcript (Trans.) fold changes for genes involved in lipid metabolism ("REACTOME metabolism of lipids and lipoproteins", combined RNA-seq and proteome *q* \< 0.001), and **c** oxidative phosphorylation that are significantly affected in NMR vs. GP (selection criteria as in **b**). Genes encoding for proteins localized to mitochondria and targets of PPARα are indicated in black and green in the annotation heat maps, respectively. **d** Fold change comparison for genes of the different complexes of the respiratory chain. Light blue and orange boxes indicate protein and transcript fold changes, respectively. **e** Mitochondrial oxygen flux supported by octanoylcarnitine and malate, compared to maximum coupled (OXPHOS) and maximum uncoupled respiration in liver of NMR (1 and 10 years old) and 6--8-month male mice. **f** Ratio of fatty acid supported respiration to maximum OXPHOS and uncoupled respiration in the liver of NMR and mouse. In **e** and **f**, reported values are averages obtained from *n* = 4 animals per experimental group ± standard deviation. \**p* \< 0.05; \*\**p* \< 0.001; n.s = not significant. Related to Additional file [4](#MOESM4){ref-type="media"}: Table S3

In order to exclude that such differences would arise from a different organelle composition of the NMR liver cells, we analyzed the distribution of fold changes for proteins belonging to different cell compartments and found slight, but significantly lower general levels of mitochondrial proteins (mean log~2~ fold change = − 0.17, *p* = 0.01, Welch two sample *t* test), and higher levels of lysosomal proteins (mean log~2~ fold change = 0.2, *p* = 0.005, Welch two sample *t* test) in NMR compared to GP.

Regarding oxidative phosphorylation, NMRs showed reduced abundance of a subset of mitochondrial respiratory chain components (Fig. [2c](#Fig2){ref-type="fig"}). Interestingly, these differences manifested almost exclusively at the protein level and affected to different extents the respiratory chain complexes, with components of complex I being the most strongly reduced (mean log~2~ fold change = − 1.53, *p* = 7.2 × 10^−5^, Welch two sample *t* test, Fig. [2d](#Fig2){ref-type="fig"}). The opposite changes of mitochondrial enzymes involved in lipid metabolism and respiratory chain components indicate that NMR livers possess a distinct composition of their mitochondrial proteome.

In order to investigate whether proteomic differences result in altered mitochondrial activity of NMR liver parenchyma, we performed ex vivo measurements of cellular respiration in liver extracts of NMR by means of high-resolution respirometry (see the "[Methods](#Sec9){ref-type="sec"}" section). We measured mitochondrial respiration from an independent group of young (1 year old, *n* = 4) and middle-aged (10 years old, *n* = 4) male NMRs and compared them to adult male mice (6--8 months, *n* = 4). We first compared the contribution of fatty acids to mitochondrial activity using octanoylcarnitine and malate as substrates. After this, maximum coupled respiration-state (OXPHOS-state) was established by further addition of glutamate and succinate. Finally, we completed the test sequence by adding carbonyl cyanide p-(trifluoromethoxy)-phenylhydrazone (FCCP) in order to achieve the maximum uncoupled respiration state. We observed (Fig. [2e](#Fig2){ref-type="fig"}) that NMRs and mice showed similar rates of mitochondrial respiration supported by fatty acids. In contrast, NMR livers showed reduced maximum mitochondrial activity compared to mouse liver. In line with the reduced abundance of respiratory chain components, mitochondrial oxygen consumption normalized per wet tissue volume was significantly reduced in both maximum OXPHOS (35% (*p* = 0.011) and 37% (*p* = 0.014) in 1- and 10-year-old NMRs, respectively; one-way ANOVA followed by Bonferroni's *t* test) and maximum uncoupled states (51% (*p* \< 0.001) and 54% (*p* \< 0.001)). This implies an approximately twofold higher fatty acid supported mitochondrial respiration in NMRs compared to mice (*p* \< 0.001 for 1-year-old NMR vs. mouse and *p* = 0.002 for 10-year-old NMR vs. mouse; one-way ANOVA followed by Bonferroni's *t* test; Fig. [2f](#Fig2){ref-type="fig"}). Taken together, our data indicate a marked rearrangement of energy metabolism in the liver of NMR characterized by an enhanced lipid metabolism and globally reduced level of mitochondrial respiration.

Cross-species- and aging-related changes correlate {#Sec5}
--------------------------------------------------

Given the existing evidences linking both lipid metabolism and oxidative phosphorylation to lifespan \[[@CR36], [@CR37]\], we investigated how these pathways are affected during aging in NMRs. We therefore compared the liver proteome of young (3--4 years old, *n* = 3) and old (\> 18 years old, *n* = 3) NMRs using quantitative mass spectrometry (Additional file [1](#MOESM1){ref-type="media"}: Table S1 and Additional file [5](#MOESM5){ref-type="media"}: Table S4). Because of the rarity of aged NMR samples, the old NMRs were obtained from a different source (zoo) than the young ones. In order to exclude potential biases due to different origin of the two sample groups, we additionally compared two groups of young (1 year old, *n* = 4) and middle-aged (\> 10 years old, *n* = 4) NMRs sourced from the same facility (Additional file [1](#MOESM1){ref-type="media"}: Table S1 and Additional file [5](#MOESM5){ref-type="media"}: Table S4). Histological evaluation of NMR liver tissue derived from the different age groups did not reveal significant inflammatory, fatty, or fibrotic changes, while an increased lipofuscin pigment deposition (a known aging marker) was detectable with aging (Additional file [6](#MOESM6){ref-type="media"}: Figure S2A).

Unsupervised hierarchical clustering based on the obtained proteome profiles confirmed an effect of aging on the NMR liver proteome in both dataset (Fig. [3a](#Fig3){ref-type="fig"} and Additional file [6](#MOESM6){ref-type="media"}: Figure S2B). In addition, protein fold changes positively correlated across the two dataset (Pearson *R* = 0.23, *p* \< 2.2 × 10^−16^, considering all the cross-quantified proteins; Pearson *R* = 0.50, *p* = 1.0 × 10^−11^, considering proteins significantly affected in both dataset (*q* \< 0.1); Additional file [6](#MOESM6){ref-type="media"}: Figure S2C). These data indicate that a distinct aging signature is detectable in the liver proteome of NMRs and that some of the changes in protein abundance already manifest in middle-aged (\> 10 years old) animals.Fig. 3The impact of aging on the NMR liver proteome. **a** Livers from three young (2.7--3.8 years old) and three old (\> 18 years old) NMRs were compared by Tandem Mass Tags (TMT)-based quantitative mass spectrometry. Hierarchical clustering based on the correlation between proteome profiles based on 5237 protein groups cross-quantified between the two age groups (Additional file [5](#MOESM5){ref-type="media"}: Table S4). **b** Gene set enrichment analysis. Gene sets are plotted according to the log~10~ value of the calculated enrichment score. Positive and negative values are used for gene sets showing higher and lower abundance in old NMRs, respectively. Selected significantly affected gene sets (*q* \< 0.05) are highlighted. The complete list of enriched gene sets is available in Additional file [7](#MOESM7){ref-type="media"}: Table S5. **c** Overlap between proteins differentially expressed in NMR vs. GP and affected by aging in NMR. **d** Comparison between cross-species and aging-related fold changes for the 99 proteins significantly different in both comparisons. **e** Cumulative distributions of significant NMR vs. GP fold differences for the 99 proteins also significantly upregulated (red) or downregulated (blue) in aging. **f** The 62 proteins with significant but opposite fold changes in both comparisons (Additional file [8](#MOESM8){ref-type="media"}: Table S6). Proteins involved in lipid/fatty acid metabolism and xenobiotic metabolism are highlighted in green and orange, respectively. Related to Additional file [5](#MOESM5){ref-type="media"}: Table S4, Additional file [6](#MOESM6){ref-type="media"}: Figure S2, Additional file [7](#MOESM7){ref-type="media"}: Table S5, and Additional file [8](#MOESM8){ref-type="media"}: Table S6

In order to gain insight into molecular networks affected by aging, we performed Gene Ontology (GO) analysis, based on 5237 protein groups quantified by at least two unique peptides between young and old NMRs (Additional file [5](#MOESM5){ref-type="media"}: Table S4). The analysis revealed biological processes that are typically affected by the aging process (Fig. [3b](#Fig3){ref-type="fig"}). These include increased inflammation and immune response-related proteins \[[@CR26]\], a known signature of aging \[[@CR38]\], and accumulation of extracellular matrix proteins \[[@CR39]\] (Additional file [7](#MOESM7){ref-type="media"}: Table S5). Interestingly, we found a statistically significant overlap between proteins differentially abundant in NMR vs. GP, and proteins whose abundance is affected by NMR aging (99 proteins, *p* = 2 × 10^−4^, Fisher's exact test, Fig. [3c](#Fig3){ref-type="fig"} and Additional file [8](#MOESM8){ref-type="media"}: Table S6). Additionally, we observed a negative correlation between protein fold changes across species and NMR aging (Pearson *R* = − 0.38, *p* = 0.0001; Fig. [3d](#Fig3){ref-type="fig"}), resulting in a significant difference between cumulative distributions of NMR vs. GP fold changes for proteins up- or downregulated in NMR aging (*p* = 0.002, Kolmogorov-Smirnov test; Fig. [3e](#Fig3){ref-type="fig"}). The directionalities of the differences indicate that proteins with decreasing expression during NMR aging tend to have a higher level in young NMR compared to GP, whereas proteins with increasing expression during NMR aging tend to start from a lower level in young NMR than in GP. Statistical significance for overlap (*p* = 0.008, Fisher's exact test), anti-correlation of fold changes (Pearson *R* = − 0.18, *p* = 1.8 × 10^−8^), and difference between cumulative distributions (*p* = 3.1 × 10^−12^, Kolmogorov-Smirnov test) can also be observed from RNA-seq data obtained from the same animals (Additional file [6](#MOESM6){ref-type="media"}: Figure S2D:F and Additional file [8](#MOESM8){ref-type="media"}: Table S6). In particular, we found among the 30 proteins up in NMR vs. GP and down during NMR aging 13 linked to lipid or fatty acid and 5 to xenobiotic metabolism (Fig. [3f](#Fig3){ref-type="fig"}). Our data suggest that this group of proteins is involved in sustaining the longevity of NMRs.

Aging affects similar pathways in both NMR and human liver {#Sec6}
----------------------------------------------------------

In order to generalize our findings to other species and in particular to human aging, we analyzed the proteome of donor liver samples from 12 individuals aged between 31 and 88 years (Additional file [1](#MOESM1){ref-type="media"}: Table S1). In this case, we used formalin-fixed and paraffin-embedded (FFPE) samples due to limited availability of healthy liver samples and quantitatively compared the proteomes using a protocol that we have recently developed \[[@CR40]\]. We and others have previously shown that this protocol for FFPE proteomics yields results that are consistent with analysis performed on fresh frozen material \[[@CR41]\] and obtained by gene expression analysis \[[@CR40]\]. Principal component analysis (PCA) based on 3211 quantified protein groups revealed separation of the proteome profiles based on the age of the donor (Fig. [4a](#Fig4){ref-type="fig"}). Guided by the PCA analysis, we split the individuals into two groups defined as adult (below 47 years of age, *n* = 6) and old (above 66 years, *n* = 5) and analyzed differential protein expression for 3064 protein groups quantified across all samples (Additional file [9](#MOESM9){ref-type="media"}: Table S7). Multiple lines of evidence indicate that aging affects similar pathways in both human and NMR liver. First, as in NMR, GO enrichment analysis revealed an age-dependent decline of proteins involved in lipid metabolism and detoxification of xenobiotics, and an increase of proteins related to immune response (Fig. [4b](#Fig4){ref-type="fig"} and Additional file [9](#MOESM9){ref-type="media"}: Table S7), and inflammation markers such as RELA/p65 (Fig. [4c](#Fig4){ref-type="fig"}). Second, enzymes involved in lipid synthesis such as ACACA and DHCR24, which were found to be expressed at higher level in NMR vs. GP and to decline during NMR aging, showed a negative correlation with the age of the donor (Fig. [4d](#Fig4){ref-type="fig"}, [e](#Fig4){ref-type="fig"}). Enzymes involved in fatty acid beta-oxidation, including ACAA2 and HADHA, also showed a trend of lower abundance in the livers from older individuals (Additional file [10](#MOESM10){ref-type="media"}: Figure S3A). Third, these changes in metabolic enzymes underline a more general reorganization of the liver proteome that is characterized by a significant reduction of both mitochondrial and peroxisomal proteins during aging in both NMR and human (Fig. [4f](#Fig4){ref-type="fig"}). Fourth, multiple proteins involved in different steps of the xenobiotic metabolism showed similar trends. Cytochrome P450s, a subset of Glutathione S-transferases (GSTs), and UDP-glucuronosyltransferases (UGTs) were in most cases expressed at higher levels in NMR vs. GP and showed an age-dependent decline both in NMR and in human (Fig. [4g](#Fig4){ref-type="fig"} and Additional file [10](#MOESM10){ref-type="media"}: Figure S3B). Taken together, these data indicate that conserved pathways linked to lipid metabolism and detoxification of xenobiotics are affected in both NMR and humans during aging.Fig. 4The impact of aging on the human liver proteome and comparison to NMR aging. **a** Principal component analysis (PCA) of the human proteome profiles based on 3211 protein groups quantified. **b** Gene Ontology (GO) enrichment analysis based on differential protein expression between adult (\< 47 years old, *n* = 6) and old (\> 66 years old, *n* = 5) donors. One donor aged 58 years old was excluded from differential expression analysis. GO categories are plotted according to the log~10~ value of the calculated enrichment *p* value. Positive and negative values are used for gene sets showing higher and lower abundance in old individuals, respectively. Selected significantly affected GO terms (*q* \< 0.05) are highlighted. The complete list of enriched GO terms is available in Additional file [9](#MOESM9){ref-type="media"}: Table S7. **c** The inflammation marker RELA shows a steady increase of abundance with age. **d**, **e** Selected examples of enzymes involved in lipid metabolism being upregulated in NMR vs. GP and decreasing during aging both in NMRs and humans. **f** Mitochondrial and peroxisomal proteins decrease with age in both the NMR and human liver. Distributions of fold changes were calculated separately for proteins assigned to different cellular compartments. Mitochondrial (*n* = 953, *p* = 1.2 × 10^−37^ Welch two sample *t* test for NMR; *n* = 716, *p* = 1.4 × 10^−21^ Welch two sample *t* test for human) and peroxisomal proteins (*n* = 95, *p* = 4.9 × 10^−6^ Welch two sample *t* test for NMR; *n* = 74, *p* = 8.9 × 10^−3^ Welch two sample *t* test for human) showed a significant lower abundance in old samples as compared to the rest of the quantified proteins. **g** Major categories of detoxifying enzymes differentially expressed in NMR vs. GP and affected by aging in both NMR and humans (only significantly affected cases are shown for each group; cutoffs: NMR vs. GP and NMR aging, combined *q* \< 0.05; human proteome aging *q* \< 0.1). Related to Additional file [9](#MOESM9){ref-type="media"}: Table S7 and Additional file [10](#MOESM10){ref-type="media"}: Figure S3

The detoxifying enzyme SULT1C3 limits lifespan in *C. elegans* {#Sec7}
--------------------------------------------------------------

In order to demonstrate a functional link between these pathways and longevity, we focused on proteins involved in xenobiotic metabolism and tested their ability to influence lifespan in the nematode *C*. *elegans.* We chose the phase-II enzyme SULT1C3 and its paralog SULT1C2, since these enzymes are among the most prominently expressed in NMR vs. GP, and they progressively decline during aging starting already at 10 years of age (Fig. [5a](#Fig5){ref-type="fig"}, Additional file [6](#MOESM6){ref-type="media"}: Figure S2B and Additional file [11](#MOESM11){ref-type="media"}: Figure S4). The *C*. *elegans* ortholog of SULTIC2/3 is SSU-1 (coded by *ssu-1*), and it was previously shown to be expressed at high levels in long-lived and stress-resistant dauer larvae (surviving up to 4 months compared to 2--3-week lifespan of a reproducing adult). High expression levels of *ssu-1* are thus associated with extended longevity also in worms \[[@CR42]\]. The feeding of wild-type worms with RNAi against *ssu-1* from L4 larval stage on resulted in significant reduction of their lifespan (median lifespan reduction of 13%) suggesting that *ssu-1* is required for normal lifespan of nematodes (Fig. [5b](#Fig5){ref-type="fig"}). The remarkable stress resistance of dauer larvae is largely due to enhanced expression of pro-survival and detoxification genes mediated by DAF-16/FOXO transcription factor \[[@CR43], [@CR44]\]. To test whether the FOXO pathway regulates the expression of *ssu-1* during adulthood and aging, we performed an epistasis experiment treating *daf-16*-deficient nematodes with *ssu-1* RNAi. The lifespan-reducing effect of the *ssu-1* RNAi is also observed in *daf-16* mutants (median lifespan reduction of 12%) (Fig. [5c](#Fig5){ref-type="fig"}), suggesting that the function of *ssu-1* in normal aging is regulated by factors other than DAF-16/FOXO. Taken together, these data show that detoxifying enzymes highly expressed in NMR can limit lifespan in a distantly related species.Fig. 5Knock-down of SSU-1 (*ssu-1)* reduces lifespan in wild-type and *daf-16(mu86)*-mutant *C*. *elegans*. **a** The orthologous mammalian phase-II conjugation enzyme SULT1C3 is significantly more abundant in NMR compared to GP, and it declines with aging. **b** Wild-type (N2, Bristol strain) and **c** *daf-16(mu86)*-mutant worms were treated with *ssu-1* and control empty vector (e.v.) RNAi from the L4 (pre-adult) developmental stage. Survival was scored daily; the significance of lifespan shortening was determined by Mantel-Cox Log rank test (*p \<* 0.0001 in both cases). The N2 experiment was repeated five times and the *daf-16(mu86)* two times with same results. For each repetition, ≥ 140 animals per condition were used. One representative replicate is shown for each experiment. Related to Additional file [11](#MOESM11){ref-type="media"}: Figure S4

Discussion {#Sec8}
==========

Cross-species comparisons based on transcriptional profiling have highlighted pathways that correlate with lifespan \[[@CR1]\]. In this work, we decided to concentrate on the NMR, as an outlier of exceptional longevity, and directly relate the identified proteome changes to the ones observed in humans, another of those outliers. In our NMR vs. GP comparative approach, we generally observed an expected correlation between transcriptome and proteome differences, confirming that a great fraction of adaptation to local ecosystems occurs via changes in gene expression that translate into abundance changes of proteins. However, we have identified changes, particularly among complexes of the mitochondrial respiratory chain, which manifested exclusively at the proteome level. Importantly some of these changes are inline with measureable difference in mitochondrial activity in NMR.

Our cross-species analysis revealed that the liver of NMRs possesses three major characteristics compared to GP: (i) lower rate of mitochondrial respiration, due to reduced protein levels of complex I; (ii) higher reliance on fatty acids for energy production, deriving from increased abundance of enzymes responsible for lipid turnover; and (iii) increased expression of detoxifying enzymes. Importantly, previous works identified GO categories and pathways related to mitochondrion and fatty acid metabolism \[[@CR8]\], as well as genes involved in the catabolism of aromatic and organic cyclic compounds \[[@CR45]\], to be differentially expressed also in NMRs vs. mice, supporting the peculiarity of NMR liver metabolism among rodents. Furthermore, a transcriptome comparison of livers from the mole-rat Spalax and *Rattus norvegicus* found enrichment of GO terms related to lipid and fatty acid metabolism among genes expressed at higher levels in Spalax \[[@CR46]\], indicating that similar metabolic adaptations might support longevity also in other mole-rat species.

Naked mole-rats have a very low metabolic rate, which reaches only 40% of the value predicted for a mammal in relation to body mass \[[@CR47]\]. They further have a very poor ability of thermoregulation and one of the lowest body temperatures of 32 °C known among mammals, which has been recorded in captivity \[[@CR48]\] and in the wild \[[@CR49]\]. These traits likely serve as energy-saving adaptations to their arid environment. Keil et al. reported an inverse relationship between body temperature and expected lifespan, which suggests a contribution of the low body temperature of NMR to their longevity \[[@CR50]\]. These adaptations, as well as their high resistance to hypoxia \[[@CR51]\], may account for a large proportion of the unique metabolic differences of NMR compared to other mammals.

Consistent with the established and published knowledge on NMR phenotypes at old age, we have shown a clear impact of aging on the NMR liver proteome that negatively affects the abundance of proteins involved in lipid metabolism and detoxification processes. The same pathways are similarly affected with aging also in mice \[[@CR52]\] and humans. Our observations support the notion of an extremely low, but detectable, rate of aging in NMRs \[[@CR53]\].

Two major questions arise from our work: how NMRs have evolved their particular liver metabolism, and how does this contribute to the extreme longevity of these animals? Multiple studies have previously linked the composition of the mitochondrial respiratory chain to lifespan extension in multiple species \[[@CR37]\]: altered composition of the respiratory chain has been shown to induce a hormetic response that can extend lifespan in *C*. *elegans* \[[@CR54]\]; mild inhibition of complex I leads to increased lifespan in the short-lived fish *Nothobranchius furzeri* \[[@CR55]\]; low abundance of the matrix arm of complex I predicts longevity in mice \[[@CR56]\]; fibroblasts isolated from long-lived human individuals including centenarians show altered mitochondrial activity with lower complex I-driven ATP synthesis \[[@CR57]\].

Similarly, lipid homeostasis and signaling has been linked to health and longevity \[[@CR36]\], and changes in lipid metabolism have been shown to mediate the positive effects of anti-aging dietary interventions. Dietary interventions such as calorie restriction (CR) or fasting influence lipid metabolism \[[@CR58], [@CR59]\]. Transcriptomic and metabolomic measurements showed that CR promotes fatty acid fueling of mitochondria in the liver of mice and it is accompanied by changes in body fat composition \[[@CR60]\]. Both fatty acid oxidation and lipid metabolism pathways as well as xenobiotic metabolism are induced by CR in the mouse liver via epigenetic reprogramming \[[@CR61]\]. Changes in lipid metabolism are mechanistically linked to activation of stress response pathways that mediate enhanced proteostasis \[[@CR62]\], and fatty acid oxidation and functional peroxisomes are required to maintain mitochondria network homeostasis and promote longevity in *C*. *elegans* \[[@CR63]\]. In humans, shifts in body composition accompany aging including a decrease of lean mass and accumulation of body fat. Fatty acid oxidation by respiring tissue decreases with age in humans \[[@CR64], [@CR65]\]; however, there are discordant reports \[[@CR66]\]. A decrease in fatty acid oxidation during aging can lead to adipose tissue accumulation and thus contribute to increased systemic inflammation, a major risk factor for aging-associated disease such as type II diabetes \[[@CR67]\]. Our data show that in both NMR and human liver, there is a progressive decline of enzymes responsible for fatty acid turnover. These alterations might contribute to changes in energy metabolism that favor the accumulation of adipose tissue and increased inflammation at older age.

From a mechanistic point of view, it is conceivable that adaptation to the particular ecosystem of NMRs has selected for characteristics of energy metabolism that in turn enabled extreme longevity via activation of stress pathways (Fig. [6](#Fig6){ref-type="fig"}). Among these, the NFE2L2 pathway, which controls the expression of many of the detoxifying enzymes that we found increased in NMR vs. GP, was shown to have enhanced activity in NMR \[[@CR13]\]. The activities of the same pathways tend to decline during aging, as shown here by the decline of their target genes in both NMR and humans and in different model organisms \[[@CR68], [@CR69]\]. It is therefore tempting to speculate that their higher basal activity in the NMR might contribute to its enhanced stress resistance and ultimately delay the aging process. In line with this hypothesis, genes encoding for respiratory electron transport chain and response to oxidative stress have been shown to be under positive selection in the NMR \[[@CR7]\]. Additionally, related molecular networks (lipid metabolism and oxidative stress pathways) are involved in the social status transition from worker to breeder in NMR \[[@CR34]\]. This indicates the existence of common evolutionary constrains and molecular mechanisms underlying longevity and eusociality, i.e., reproductive animals' lifelong fecundity coupled with extraordinary life- and healthspan in the NMR \[[@CR70]\] and even extended lifespan in other mole-rats \[[@CR71], [@CR72]\] and longevity. Further work is required to elucidate in detail which aspects of liver metabolism are sufficient to promote lifespan, and what is the molecular basis mediating positive systemic effects that support organism health by delaying aging in NMR.Fig. 6Proposed model linking metabolic changes to stress response/detoxifying pathways in NMR and during aging

Methods {#Sec9}
=======

Ethics approval and consent to participate {#Sec10}
------------------------------------------

For NMR and GP samples, the sampling and animal procedures were approved by the local ethics committee of the "Landesamt für Gesundheit und Soziales", Berlin, Germany (reference numbers \#ZH 156, G02217/12, and T 0073/15), and were compliant with the national and institutional animal care guidelines. Human liver tissue samples were provided by the tissue bank of the National Center for Tumor Diseases (NCT, Heidelberg, Germany) in accordance with the regulations of the tissue bank and the approval of the ethics committee of Heidelberg University.

Samples {#Sec11}
-------

Young and middle-aged NMR and GP liver tissue samples were obtained at the Leibniz Institute for Zoo and Wildlife Research, IZW (Berlin, Germany). Old NMR liver tissue samples were obtained from the Stockholm Zoo Skansen. All the animals were sacrificed and did not die of natural causes. NMRs from the Stockholm zoo were euthanized as part of veterinary management by the zoo. NMRs were kept inside artificial burrow systems, consisting of acrylic glass containers interconnected with tubes. Except during cleaning and management procedures, animals were kept in complete darkness and supplied daily ad libitum with fresh vegetables. Temperature and humidity were kept stable at 27.0 ± 2.0 °C and 85.0 ± 5.0%, respectively. GPs (breed: Dunkin Hartley HsdDhl:DH, Harlan Laboratories, AN Venray, Netherlands) were kept pairwise in standardized GP cages with a 12-h light-dark cycle. They were fed commercial pellets and fresh vegetables daily; hay and vitamin C-enriched water were provided ad libitum. Temperature and humidity ranged between 18.0 ± 2.0 °C and 45.0 ± 5.0%, respectively. For tissue collection, animals were euthanized by surgical decapitation under general anesthesia (Isofluran CP, CP-Pharma, Burgdorf, Germany). Tissue samples were fresh frozen and stored in liquid nitrogen before transcriptome or proteome analysis.

Human liver samples were obtained in a transplant setting to check the quality of the donor liver by histology before implantation. The age of the donors ranges from 31 to 88. The tissue samples were formalin fixed, paraffin embedded (FFPE), and slides were stained with hematoxylin and eosin (H&E). These full-section H&E slides were re-evaluated by a trained pathologist (SS) confirming that each of the samples used for proteomic analyses did not show any overt pathomorphological changes (e.g., necrosis or significant inflammatory or fatty changes).

RNA sequencing analysis {#Sec12}
-----------------------

### Reference transcripts {#Sec13}

Reference transcripts for NMR are based on recently published de novo transcriptome assembly \[[@CR73]\]. Reference transcripts for GP were obtained by de novo transcriptome assembly of ten different tissue samples as described in \[[@CR34]\], using the human transcriptome as a reference for gene symbol assignment. Both transcript sets were mapped to the corresponding genomes (NMR UCSC hetgla2, GP UCSC cavpor3) in two steps: BLAT was used to identify the locus, and then SPLIGN (v1.39.8) was applied to splice align the transcript sequence within BLAT locus.

### Transcript quantification {#Sec14}

For NMR age comparison, RNA-seq data were aligned to the reference genome utilizing STAR (v2.4.1d) with a maximum mismatch of 6% and a minimum aligned length of 90%. Reads mapped to multiple loci were discarded. Gene expression was quantified using HTSEQ (v0.6.1p1) based on the aligned reference transcripts. For cross-species comparison (NMR vs. GP), orthologous transcribed regions were determined using PosiGene \[[@CR74]\] with parameter "prank=0 max_anchor_gaps_hard=100 rs=NMR." RNA-seq data were aligned to the corresponding orthologous transcribed regions in NMR and GP reference transcripts using bowtie2 (2.2.9) with the parameter "\--very-sensitive-local." DESeq2 (v1.6.3) was used to identify DEGs after correction of *p* values using Benjamini-Hochberg (FDR, denoted as "*q*") for NMR aging and cross-species comparison.

Sample preparation for mass spectrometry {#Sec15}
----------------------------------------

### NMR and GP fresh frozen liver samples for label-free cross-species comparison {#Sec16}

Frozen tissue samples of NMR and GP livers (between 20 and 40 mg, Additional file [1](#MOESM1){ref-type="media"}: Table S1) were collected into Precellys Lysing kit tubes (Keramik-kit 1.4/2.8 mm, 2 mL (CKM)) containing 200 μL of protein solubilization buffer (80 μM Tris pH 8.0, 80 μM DTT and 4% SDS) and processed directly. Samples were homogenized in the Precellys 24 homogenizer (Bertin Instruments, France) at 5000 rpm for 30 s at 4 °C. Samples were then spun down and the supernatant transferred to a 1.5-mL Eppendorf tube. Samples were sonicated using a Bioruptor Plus (Diagenode) for 7.5 min (5 cycles, 1 min on, 30 s off, 20 °C) using the high setting, and then boiled for 10 min at 95 °C. A second round of sonication (as before) followed the boiling. Samples were spun down at 20800×*g* for 5 min and the lysate supernatant transferred to fresh tubes. Protein concentration was determined by BCA assay (Pierce) using standard protocol and adjusted to 10 μg/μL using solubilization buffer. Five microliters of tissue lysate, corresponding to 50 μg protein, was taken for preparation for MS. Cysteine residues were alkylated by adding 1 μL of 200 mM iodoacetamide to a final concentration of 15 mM (incubated for 30 min at room temperature in the dark). Reaction was quenched by addition of 1 μL of 200 mM DTT. Sample clean-up proceeded following a modified SP3 protocol. Sera-Mag Speed Beads (\#45152105050250 and \#65152105050250, Thermo Scientific) were mixed 1:1, rinsed with water, and stored as a 40-μg/μL stock solution in 4 °C, as described in \[[@CR75]\]. Four microliters of beads stock was added to the reaction tube and mixed by pipetting, then 11 μL acetonitrile containing 5% (*v*/*v*) formic acid was added. Samples were incubated for 8 min at room temperature to allow protein bindings to the beads. Next, tubes were placed on the magnetic rack. Supernatant was removed and discarded. Beads were washed twice with 180 μL of 70% (*v*/*v*) ethanol and once with 180 μL of 100% acetonitrile. After removal of acetonitrile, beads were air-dried for 60 s and then resuspended in 7 μL of digestion buffer (6 μL 4 M urea in 100 mM ammonium bicarbonate and 1 μL of 1 μg/μL of LysC (Wako)). Samples were sonicated for 5 min in water bath, incubated for 5 min at 37 °C, and then mixed by pipetting. Digestion was allowed to proceed for 4 h at 37 °C. After the first step of digestion, beads were resuspended by pipetting, urea was diluted to the final concentration of 1.5 M, and 1 μL of 1 μg/μL of sequencing grade trypsin (Promega) was added to samples. Digestion was performed overnight at 37 °C. After digestion, beads were resuspended by pipetting. One hundred percent acetonitrile was added to the final concentration of 95% (*v*/*v*), and samples were incubated for 8 min at room temperature. Tubes were placed on the magnetic rack and washed twice with 100% acetonitrile. Supernatant was removed and beads air-dried and reconstituted in 20 μL of 2% DMSO followed by 5 min of sonication in the water bath. Samples were resuspended by pipetting and placed on the magnetic rack. Supernatant containing peptides was transferred to a fresh tube and acidified with 2 μL of 1% (*v*/*v*) formic acid prior to pre-fractionation by high pH reverse phase chromatography. Offline high pH reverse phase fractionation was performed using an Agilent 1260 Infinity HPLC System equipped with a binary pump, degasser, variable wavelength UV detector (set to 220 and 254 nm), peltier-cooled autosampler (set at 10 °C), and a fraction collector. The column was a Waters XBridge C18 column (3.5 μm, 100 × 1.0 mm, Waters) with a Gemini C18, 4 × 2.0 mm SecurityGuard (Phenomenex) cartridge as a guard column. The solvent system consisted of 20 mM ammonium formate (pH 10.0) as mobile phase (A) and 100% acetonitrile as mobile phase (B). The separation was accomplished at a mobile phase flow rate of 0.1 mL/min using a linear gradient from 100% A to 35% B in 61 min. Thirty-four fractions were collected along with the LC separation, which were subsequently pooled into 10 fractions. Pooled fractions were dried in a Speed-Vac and then stored at − 80 °C until LC-MS/MS analysis.

### NMR frozen liver samples for TMT-based comparison of young, middle-aged, and old samples {#Sec17}

For each experimental animal (Additional file [1](#MOESM1){ref-type="media"}: Table S1), 100 μg protein lysate from the bead-beaten stock of tissue described above were taken up to a final volume of 50 μL with 100 mM HEPES buffer, pH 8.5. Five microliters of 2% SDS was added, prior to biorupting (5 cycles, 1 min on, 30 s off, 20 °C) at the highest settings. Samples were spun down at 20800×*g* for 1 min, and the lysate supernatant transferred to fresh tubes. Reduction was performed with 2.9 μL DTT (200 mM) for 15 min at 45 °C before alkylation with 200 mM IAA (5 μL, 30 min, room temperature, in the dark). Proteins were then precipitated with four volumes of ice cold acetone to one volume sample and left overnight at − 20 °C. The samples were then centrifuged at 20800×*g* for 30 min, 4 °C. After removal of the supernatant, the precipitates were washed twice with 500 μL 80% (*v*/*v*) acetone (ice cold). After each wash step, the samples were vortexed, then centrifuged again for 2 min at 4 °C. The pellets were then allowed to air-dry before being dissolved in digestion buffer (50 μL, 3 M urea in 0, 1 M HEPES, pH 8; 1 μg LysC) and incubated for 4 h at 37 °C with shaking at 600 rpm. Then, the samples were diluted 1:1 with milliQ water (to reach 1.5 M urea) and were incubated with 1 μg trypsin for 16 h at 37 °C. The digests were then acidified with 10% trifluoroacetic acid and then desalted with Waters Oasis® HLB μElution Plate 30 μm in the presence of a slow vacuum. In this process, the columns were conditioned with 3 × 100 μL solvent B (80% (*v*/*v*) acetonitrile; 0.05% (*v*/*v*) formic acid) and equilibrated with 3 × 100 μL solvent A (0.05% (*v*/*v*) formic acid in milliQ water). The samples were loaded, washed three times with 100 μL solvent A, and then eluted into PCR tubes with 50 μL solvent B. The eluates were dried down with the speed vacuum centrifuge and dissolved in 200 mM HEPES buffer, pH 8.5 for TMT labeling. Twenty-five micrograms of peptides were taken for each labeling reaction at 1 μg/μL concentration. TMT-6plex reagents for old vs. young comparison (TMT-10plex for middle-aged vs. young comparison) (Thermo Scientific) were reconstituted in 41 μL 100% anhydrous DMSO. TMT labeling was performed by addition of 2.5 μL of the TMT reagent. After 30 min of incubation at room temperature, with shaking at 600 rpm in a thermomixer (Eppendorf), a second portion of TMT reagent (2.5 μL) was added and incubated for another 30 min. The reaction was quenched with 1 μL of 20 mM lysine in 100 mM ammonium bicarbonate. After checking labeling efficiency, samples were pooled (48 μg total), cleaned once again with Oasis and subjected to high pH fractionation prior to MS analysis. For middle-aged vs. young comparison, two additional samples were generated by pooling the young and middle-aged samples separately and used to fill the two remaining TMT channels. Offline high pH reverse phase fractionation was performed as described above with the following modifications for TMT-labeled samples: (i) the separation was accomplished at a mobile phase flow rate of 0.1 mL/min using a non-linear gradient from 95% A to 40% B in 91 min; (ii) 48 fractions were collected along with the LC separation that were subsequently pooled into 16 fractions.

### Human FFPE liver samples {#Sec18}

The specimens were cut on a microtome into 5-μm-thick sections, mounted on glass slides and processed with a modified version of the protocol described in \[[@CR40]\]. Slides were deparaffinized in xylene for 2 × 5 min, rehydrated in 100% ethanol for 2 × 5 min, and then washed in 96% (*v*/*v*), 70% (*v*/*v*), 50% (*v*/*v*) ethanol and milliQ water for 1 × 5 min each. Region of interest were gently scraped using a scalpel and transferred to a PCR tube containing 100 μL of protein solubilization buffer (80 μM Tris pH 8.0, 80 μM DTT, and 4% SDS) and processed directly. Samples were sonicated using a Bioruptor Plus (Diagenode) for 25.2 min (15 cycles, 1 min on, 30 s off) at 20 °C using the high setting, and then boiled for 1 h at 99 °C. Sonication followed by boiling was performed twice. Cysteine residues were alkylated by adding 200 mM iodoacetamide to a final concentration of 15 mM (incubated for 30 min at room temperature in the dark). Reaction was quenched by addition of 10 μL of 200 mM DTT. Protein were then acetone precipitated, digested, and desalted as described above for NMR samples (aging comparison), with the exceptions that 0.5 μg of both LysC and trypsin were used instead of 1 μg to accommodate for the lower amount of protein extract employed, and no TMT labeling was performed.

Mass spectrometry data acquisition {#Sec19}
----------------------------------

### Label-free analysis of NMR and GP liver samples {#Sec20}

For label-free experiments, each fraction from the four GP and four NMR samples, separated by high pH, were resuspended in 10 μL reconstitution buffer (5% (*v*/*v*) acetonitrile, 0.1% (*v*/*v*) TFA in water) and 8 μL were injected. Peptides were separated using the nanoAcquity UPLC system (Waters) fitted with a trapping (nanoAcquity Symmetry C18, 5 μm, 180 μm × 20 mm) and an analytical column (nanoAcquity BEH C18, 2.5 μm, 75 μm × 250 mm). The outlet of the analytical column was coupled directly to an Orbitrap Fusion Lumos (Thermo Fisher Scientific) using the Proxeon nanospray source. Solvent A was water, 0.1% (*v*/*v*) formic acid, and solvent B was acetonitrile, 0.1% (*v*/*v*) formic acid. The samples were loaded with a constant flow of solvent A at 5 μL/min, onto the trapping column. Trapping time was 6 min. Peptides were eluted via the analytical column at a constant flow of 0.3 μL/min, at 40 °C. During the elution step, the percentage of solvent B increased in a linear fashion from 5 to 7% in 10 min, then from 7% B to 30% B in a further 105 min and to 45% B by 130 min. The peptides were introduced into the mass spectrometer via a Pico-Tip Emitter 360 μm OD × 20 μm ID; 10 μm tip (New Objective), and a spray voltage of 2.2 kV was applied. The capillary temperature was set at 300 °C. Full-scan MS spectra with mass range 375--1500 *m/z* were acquired in profile mode in the Orbitrap with resolution of 120,000 FWHM using the quad isolation. A first batch of samples (NMR F1-6074, M1-1449; GP \#18, \#19) was acquired with the following settings. The RF on the ion funnel was set to 60%. The filling time was set at maximum of 100 ms with an AGC target of 4 × 10^5^ ions and 1 microscan. The peptide monoisotopic precursor selection was enabled along with relaxed restrictions if too few precursors were found. The most intense ions (instrument operated for a 3 s cycle time) from the full scan MS were selected for MS2, using quadrupole isolation and a window of 1.6 Da. An intensity threshold of 5 × 10^3^ ions was applied. Higher-energy collisional dissociation (HCD) was performed with collision energy of 35%. A maximum fill time of 30 ms with an AGC target of 1 × 10^4^ for each precursor ion was set. MS2 data were acquired in centroid in the ion trap, in Rapid scan mode, with fixed first mass of 120 *m/z*. The dynamic exclusion list was with a maximum retention period of 60 s and relative mass window of 10 ppm. In order to improve the mass accuracy, internal lock mass correction using a background ion (*m/z* 445.12003) was applied. For data acquisition and processing of the raw data, Xcalibur 4.0 (Thermo Scientific) and Tune version 2.0 were employed. As a consequence of method optimization, the following parameters were changed for a second batch of samples (NMR \#0713, \#4925; GP \#23, \#28): RF on the ion funnel was set to 40%, AGC target to 2 × 10^5^, quadrupole isolation window to 1.4 Da, HCD collision energy to 30%, fill time to 300 ms, AGC target to 2 × 10^3^, and the instrument was set to inject ions for all available parallelizable time. Since the two batches of samples were block randomized (i.e., both contained the same number of NMR and GP samples), the usage of two different methods did not influence the outcome of our comparison, as shown by the expected clustering of the samples according to the species of origin (Fig. [1a](#Fig1){ref-type="fig"}).

### TMT analysis of NMR young, middle-aged, and old samples {#Sec21}

For TMT experiments, fractions were resuspended in 10 μL reconstitution buffer (5% (*v*/*v*) acetonitrile, 0.1% (*v*/*v*) TFA in water) and 3.5 μL were injected. Peptides were analyzed using the same LC-MS/MS setup described above with the following modifications. Peptides were eluted using a linear gradient from 5 to 7% in 10 min, then from 7% B to 30% B in a further 105 min and to 45% B by 130 min. Full-scan MS spectra with mass range 375--1500 *m/z* were acquired in profile mode in the Orbitrap with resolution of 60,000 FWHM using the quad isolation. The RF on the ion funnel was set to 40%. The filling time was set at maximum of 100 ms with an AGC target of 4 × 10^5^ ions and 1 microscan. The peptide monoisotopic precursor selection was enabled along with relaxed restrictions if too few precursors were found. The most intense ions (instrument operated for a 3 s cycle time) from the full scan MS were selected for MS2, using quadrupole isolation and a window of 1 Da. HCD was performed with collision energy of 35%. A maximum fill time of 50 ms for each precursor ion was set. MS2 data were acquired with fixed first mass of 120 *m*/*z*. The dynamic exclusion list was with a maximum retention period of 60 s and relative mass window of 10 ppm. For the MS3, the precursor selection window was set to the range 400--2000 *m*/*z*, with an exclude width of 18 *m*/*z* (high) and 5 *m*/*z* (low). The most intense fragments from the MS2 experiment were co-isolated (using Synchronus Precursor Selection = 8) and fragmented using HCD (65%). MS3 spectra were acquired in the Orbitrap over the mass range 100--1000 *m*/*z* and resolution set to 30,000 FWMH. The maximum injection time was set to 105 ms, and the instrument was set not to inject ions for all available parallelizable time.

### Data-independent acquisition (DIA) for human FFPE samples {#Sec22}

Peptides were spiked with retention time HRM kit (Biognosys AG) and analyzed using the same LC-MS/MS setup described above with the following modifications. Approx. 1 μg for data-dependent acquisition (DDA) and 3 μg for DIA analysis were loaded. Peptides were eluted via a non-linear gradient from 0 to 40% in 120 min. Total runtime was 145 min, including clean-up and column re-equilibration. The RF lens was set to 30%. For spectral library generation, a pooled sample was generated by mixing equal portion of each sample, injected six times, and measured in DDA mode. The conditions for DDA data acquisition were as follows: Full-scan MS spectra with mass range 350--1650 *m*/*z* were acquired in profile mode in the Orbitrap with resolution of 60,000 FWHM. The filling time was set at maximum of 50 ms with limitation of 2 × 10^5^ ions. The "Top Speed" method was employed to take the maximum number of precursor ions (with an intensity threshold of 5 × 10^4^) from the full-scan MS for fragmentation (using HCD collision energy, 30%) and quadrupole isolation (1.4 Da window) and measurement in the Orbitrap (resolution 15,000 FWHM, fixed first mass 120 *m*/*z*), with a cycle time of 3 s. The MIPS (monoisotopic precursor selection) peptide algorithm was employed but with relaxed restrictions when too few precursors meeting the criteria were found. The fragmentation was performed after accumulation of 2 × 10^5^ ions or after filling time of 22 ms for each precursor ion (whichever occurred first). MS/MS data were acquired in centroid mode. Only multiply charged (2^+^--7^+^) precursor ions were selected for MS/MS. Dynamic exclusion was employed with maximum retention period of 15 s and relative mass window of 10 ppm. Isotopes were excluded. For data acquisition and processing, Tune version 2.1 was employed.

For the DIA data acquisition, the same gradient conditions were applied to the LC as for the DDA and the MS conditions were varied as follows: Full-scan MS spectra with mass range 350--1650 *m*/*z* were acquired in profile mode in the Orbitrap with resolution of 120,000 FWHM. The filling time was set at maximum of 20 ms with limitation of 5 × 10^5^ ions. DIA scans were acquired with 34 mass window segments of differing widths across the MS1 mass range with a cycle time of 3 s. HCD fragmentation (30% collision energy) was applied, and MS/MS spectra were acquired in the Orbitrap with a resolution of 30,000 FWHM over the mass range 200--2000 *m*/*z* after accumulation of 2 × 10^5^ ions or after filling time of 70 ms (whichever occurred first). Ions were injected for all available parallelizable time. Data were acquired in profile mode.

Mass spectrometry data analysis {#Sec23}
-------------------------------

### Label-free cross-species comparison of NMR and GP liver samples {#Sec24}

The Andromeda search engine \[[@CR76]\], part of MaxQuant (version 1.5.3.28) \[[@CR77]\], was used to search the data. The data for GP and NMR were searched separately against translated species-specific reference transcripts (see the "[RNA sequencing analysis](#Sec12){ref-type="sec"}" section). Databases with a list of common contaminants were appended in both cases. The data were searched with the following modifications: carbamidomethyl (C) (fixed), and oxidation (M) and acetyl (protein N-term) (variable). The mass error tolerance for the full-scan MS spectra was set at 20 ppm and for the MS/MS spectra at 0.5 Da. A maximum of two missed cleavages were allowed. Peptide and protein level 1% FDR were applied using a target-decoy strategy \[[@CR78]\]. iBAQ (label-free quantification) values from the MaxQuant output were used to perform cross-species differential protein expression analysis using scripts written in R (v3.4.1). After removal of reverse and contaminant hits, only protein groups quantified by at least two unique peptides were retained. Common human gene symbols were used to combine iBAQ values for NMR and GP samples. Only protein groups quantified in at least two animals per group were retained when comparing protein abundances between NMR and GP. To reduce technical variation, data were log~2~ transformed and quantile-normalized using the preprocessCore library. Protein differential expression was evaluated using the limma package \[[@CR79]\]. Differences in protein abundances were statistically determined using the Student's *t* test moderated by the empirical Bayes method. *P* values were adjusted for multiple testing using the Benjamini-Hochberg method (FDR, denoted as "*q*") \[[@CR80]\] (Additional file [2](#MOESM2){ref-type="media"}: Table S2).

### TMT-based analysis of young, middle-aged, and old NMR livers {#Sec25}

TMT data were processed using Proteome Discoverer v2.0 (Thermo Fisher Scientific). Data were searched against the NMR fasta database using Mascot v2.5.1 (Matrix Science) with the following settings: Enzyme was set to trypsin, with up to one missed cleavage. MS1 mass tolerance was set to 10 ppm and MS2 to 0.5 Da. Carbamidomethyl cysteine was set as a fixed modification and oxidation of methionine as variable. Other modifications included the TMT-6plex modification from the quan method used. The quan method was set for reporter ions quantification with HCD and MS3 (mass tolerance, 20 ppm). The false discovery rate for peptide-spectrum matches (PSMs) was set to 0.01 using Percolator \[[@CR81]\]. Reporter ion intensity values for the filtered PSMs were exported and processed using in-house written R scripts to remove common contaminants and decoy hits Additionally, only PSMs having reporter ion intensities above 1 × 10^3^ in all the relevant TMT channels were retained for quantitative analysis. Only protein groups quantified by at least two unique peptides were analyzed for differential expression. Data were analyzed using the MSnbase package \[[@CR82]\]. Reporter ion intensities were log~2~-transformed and normalized using the vsn package \[[@CR83]\]. Peptide-level data were summarized into their respective protein groups by taking the median value. Differential protein expression was assessed using the limma package, as described above (Additional file [5](#MOESM5){ref-type="media"}: Table S4).

### DIA analysis of FFPE human samples {#Sec26}

For library creation, the DDA data was searched using the Andromeda search engine built in MaxQuant (version 1.5.3.28). The data were searched against a human database (Swiss-Prot entries of the Uniprot KB database release 2016_01, 20198 entries) with a list of common contaminants appended, as well as the HRM peptide sequences. The data were searched with the following modifications: carbamidomethyl (C) (fixed) and oxidation (M)/acetyl (protein N-term) (variable). The mass error tolerance for the full-scan MS and MS/MS spectra was set at 20 ppm. A maximum of one missed cleavage was allowed. The identifications were filtered to satisfy FDR of 1% on peptide and protein level. A spectral library was created from the MaxQuant output of the DDA runs combined using Spectronaut (version 10, Biognosys AG). This library contained 34,014 precursors, corresponding to 3295 protein groups using Spectronaut protein inference. DIA data were then uploaded and searched against this spectral library. Precursor matching, protein inference, and quantification were performed in Spectronaut using default settings \[[@CR84]\]. Differential protein expression was evaluated using a pairwise *t* test performed at the precursor level followed by multiple testing correction according to \[[@CR85]\]. The data (candidate table, Additional file [9](#MOESM9){ref-type="media"}: Table S7) was exported from Spectronaut and used for further data analyses (see below).

Data analysis {#Sec27}
-------------

For integrated analysis of RNA-seq and proteomic data, transcripts and protein groups were matched using the corresponding gene symbol, *p* values were combined using the Fisher method, followed by correction for multiple testing using the Benjamini-Hochberg method (FDR, denoted as "*q*") \[[@CR80]\]. Gene set enrichments (Figs. [2a](#Fig2){ref-type="fig"} and [3b](#Fig3){ref-type="fig"}) were performed with the R package *gage* \[[@CR86]\] using gene set definitions from the Molecular Signatures Database (MSigDB, C2 v5.1) \[[@CR87]\]. Gene Ontology enrichment analysis (Fig. [4b](#Fig4){ref-type="fig"}) was performed using GOrilla \[[@CR88]\] giving as input the list of quantified proteins that were ranked according to the level of differential expression (fold change).

Measurements of mitochondrial activity {#Sec28}
--------------------------------------

Mitochondrial respiration was measured in homogenized liver tissue samples of NMRs and mice by means of high-resolution respirometry using the Oroboros® Oxygraph-2K (Oroboros Instruments, Innsbruck, Austria). This device allows for simultaneous recording of the O~2~ concentration in two parallel chambers calibrated for 2 mL of respiration medium containing 110 mM D-Sucrose (Sigma 84097), 60 mM K-lactobionate (Aldrich 153516), 0.5 mM ethylene glycol tetra acetic acid (Sigma E4378), 1 g/L bovine serum albumin free from essentially fatty acids (Sigma A 6003), 3 mM MgCl~2~ (Scharlau MA0036), 20 mM taurine (Sigma T0625), 10 mM KH~2~PO~4~ (Merck 104873), 20 mM HEPES (Sigma H7523), adjusted to pH 7.1 with KOH and equilibrated with 21% O~2~ at 37 °C. Mitochondrial respiration was quantified in terms of oxygen flux (*J*O~2~) calculated as the rate of change of the O~2~ concentration in the chambers normalized for wet tissue volume.

The liver tissue homogenates were generated from 40 to 50 mg of wet tissue samples suspended in 2 mL of ice-cold respiration medium. Aliquots of the homogenates were added to each oxygraph chamber in order to obtain a final amount of 4 mg of NMR liver tissue or 2 mg of mouse liver tissue per chamber. The different amount of tissue was chosen in order to obtain similar absolute *J*O2 values, i.e., *J*O2 values not normalized per wet weight, in both species. Every sample was measured in duplicates; the mean values from both chambers were used for statistical analysis.

The titration sequence used for the experiments was as follows: 2 mM malate + 1 mM octanoylcarnitine, 5 mM ADP, 10 μM cytochrome c, 10 mM glutamate, 10 mM succinate, 2.5 μM oligomycin, 1 μM carbonyl cyanide p-(trifluoromethoxy)-phenylhydrazone (FCCP), 0.5 μM rotenone, and 5 μM antimycin A. The *J*O~2~ values after addition of octanoyl carnitine, malate, ADP, and cytochrome c allow quantifying fatty acid oxidation. The addition of cytochrome c after ADP is required to test the integrity of the outer mitochondrial membrane. If homogenization steps damaged the mitochondrial membrane, addition of cytochrome c induces an increase of the respiratory values. The maximum oxidative capacity of the mitochondrial respiratory chain in the coupled state (maximum OxPhos) was then determined after the subsequent addition of glutamate and succinate. Further injections of the ATP synthase inhibitor oligomycin and of the uncoupler FCCP allowed obtaining the maximum respiratory activity in the uncoupled state. In the next two steps, complex I and complex III were sequentially inhibited by administration of rotenone and antimycin A respectively. Finally, sequentially injecting 2 mM ascorbate and 0.5 mM of the complex IV substrate tetramethyl phenylene diamine (TMPD) in the parallel chambers allowed for selectively quantifying the activity of the cytochrome-c-oxidase (COX). Part of the *J*O~2~ induced by the injection of TMPD is caused by auto-oxidation of this compound. Therefore, inhibiting the COX by 40 μM sodium sulfide allowed to quantify and thus to subtract this auto-oxidation-related part from the total *J*O~2~ value under TMPD.

*C*. *elegans* lifespan measurements {#Sec29}
------------------------------------

HT115 bacteria containing specific RNAi constructs were grown on lysogeny broth agar plates supplemented with ampicillin and tetracycline. Plates were kept at 4 °C. Overnight cultures were grown in lysogeny broth media containing ampicillin. RNAi expression was induced by adding 1 mM isopropylthiogalactoside (IPTG) and incubating the cultures at 37 °C for 20 min before seeding bacteria on NGM agar supplemented with ampicillin and 3 mM IPTG. Synchronized L4 larvae of N2, Bristol strain, and *daf-16(mu86)* strain were placed on 60-mm dishes containing RNAi expressing bacteria at a density of 70 worms per plate; two replica plates were used for each condition providing a sum of 140 total animals per condition at the start of the test. Worms were transferred to new plates on a daily basis until adulthood day 6 (AD6) and later transferred to new plates every 3--4 days. The number of dead animals was scored daily. Worms were kept at 20 °C from embryonic stage on and until the end of the experiment. The analysis of the lifespan data including statistics was performed using GraphPad Prism software.

Conclusions {#Sec31}
===========

Using an integrated proteomic and transcriptomic approach, we have revealed differences in the liver proteome of the long-lived NMRs compared to the shorter-lived GPs. We have confirmed a preferential way of utilizing fatty acids to fuel respiration in NMRs, reflecting a distinct composition of their mitochondria. Furthermore, we have identified a progressive signature of aging that manifest in the liver of NMRs on a molecular level. Interestingly, functionally related groups of proteins, including enzymes of the detoxification pathways, were similarly affected by aging in both NMR and human liver samples. This underlines a direct link between the aging processes of these two species. It remains to be demonstrated whether the aging-affected pathways influence the health status of old NMRs and limit their lifespan, as we have shown to be the case in the nematode C. elegans.
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================
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Additional file 1:**Table S1.** List of used animals. (XLSX 36 kb) Additional file 2:**Table S2.** NMR vs. GP dataset, contains differential expression analysis for proteomic and transcriptomic data and integrated RNAseq proteome analysis of NMR and GP livers. (XLS 4142 kb) Additional file 3:**Figure S1.** (A) Heatmap showing genes that displayed discordant NMR vs. GP fold changes at the transcript and protein level. Only cases significant in both comparisons (*q* \< 0.1) are shown. (B and C) Comparison of transcript levels of *PRDX1* and *TXNRD1* across multiple tissues. For both genes, transcript levels are increased in NMR vs. GP in the liver (*q *\< 2.2 × 10^− 300^ for *PRDX1*; *q* = 1.5 × 10^− 45^ for *TXNRD1*), while they show similar abundances in the other tissues examined. RNAseq data for heart, skin, kidney and cerebellum were obtained from \[[@CR34]\]. Related to Fig. [1](#Fig1){ref-type="fig"} and Additional file [1](#MOESM1){ref-type="media"}: Table S1 and Additional file [2](#MOESM2){ref-type="media"}: Table S2. (PDF 488 kb) Additional file 4:**Table S3.** Excel workbook (.xlsx), NMR vs. GP gene set enrichment, contains significantly affected gene sets from the proteomic analysis. (XLSX 65 kb) Additional file 5:**Table S4.** Excel workbook (.xlsx), NMR aging dataset, contains differential expression analysis for proteomic and transcriptomic data and integrated RNAseq proteome analysis of old vs. young NMR livers, and proteomic analysis of middle-aged vs. young NMR livers. (XLS 6040 kb) Additional file 6:**Figure S2.** Comparison of liver proteomes between middle-aged and young NMRs, and correlation analysis of transcript level differences in NMR vs. GP and NMR aging. (A) Representative micrographs show H&E stained (FFPE) liver tissue sections from NMRs of the indicated age groups. Scale bar = 100 μm. (B) Livers from 4 young (1 yo) and 4 middle-aged (\> 10 yo) NMRs were compared by Tandem Mass Tags (TMT) based quantitative mass spectrometry. Hierarchical clustering based on the correlation between proteome profiles based on 4936 protein groups cross-quantified between the two age groups (Additional file [5](#MOESM5){ref-type="media"}: Table S4). (C) Comparison of protein fold changes calculated between old vs. young (x-axis) and middle-aged vs. young (y-axis) NMRs. Colored dots indicate proteins significant (*q* \< 0.1) in both comparisons. The names of selected proteins that show consisted fold changes in the two comparisons are indicated. (D) Significant overlap between differentially expressed genes (DEGs) in NMR vs. GP and in aging of NMR. (E) Comparison between cross-species and aging-related fold changes for the 875 DEGs significant in both comparisons (q \< 0.01) shows significant negative correlation. (F) Cumulative distributions of NMR vs. GP fold changes for the 875 DEGs also significantly up- (red) or down- (blue) regulated in NMR aging. The x-axis was restricted to ±8 for display purpose. Related to Fig. [3](#Fig3){ref-type="fig"}, Additional file [5](#MOESM5){ref-type="media"}: Table S4 and Additional file [8](#MOESM8){ref-type="media"}: Table S6. (PDF 13567 kb) Additional file 7:**Table S5.** NMR aging gene set enrichment, contains significantly affected gene sets from the proteomic analysis. (XLSX 47 kb) Additional file 8:**Table S6.** Comparison of cross-species and NMR aging dataset for proteomic and transcriptomic data. (XLS 2175 kb) Additional file 9:**Table S7.** Human aging dataset, contains differential expression analysis for proteomic data for human liver samples from young and old donors. (XLS 1778 kb) Additional file 10:**Figure S3.** Examples of enzymes involved in fatty acid beta-oxidation and xenobiotic metabolism that decrease during aging in human liver. (A) Additional examples of enzymes involved in lipid metabolism decreasing during aging in human liver. (B) Detoxifying enzymes decreasing during aging in both NMR and humans. Only significantly affected genes are shown; cut offs: NMR aging, combined *q* \< 0.05; human proteome aging *q *\< 0.1; n.s. = no significant cases detected. Related to Fig. [4](#Fig4){ref-type="fig"}. (PDF 386 kb) Additional file 11:**Figure S4.** SULT1C2 decreases with aging in NMR. Related to Fig. [5](#Fig5){ref-type="fig"}. (PDF 328 kb)
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Availability of data and materials {#FPar1}
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RNA-seq data of GP used in de novo transcriptome assembly for cross-species comparisons were generated by \[[@CR34]\] and are available at the Sequence Read Archive (SRP104222). RNA-seq data for NMR aging and cross-species comparisons were generated by \[[@CR2], [@CR34]\] and are available in the Gene Expression Omnibus repository (GSE98744). The corresponding gene annotation for NMR and GP are available as a gff3-file (<ftp://genome.leibniz-fli.de/pub/nmr2017/>). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE \[[@CR89]\] partner repository with the dataset identifier PXD008720.

IH, EC, SH, and SNS performed the experiments and analyzed the data; MB, AS, KS, NR, and KH analyzed the data; MP, TH, AO, SS, JMK, KS, EC, and ME designed the experiments; MP, TH, and AO oversaw the project and wrote the manuscript. All authors read and approved the final manuscript.

The authors declare that they have no competing interests.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
